The experience of "medicine companions" to support adherence to antiretroviral therapy: Quantitative and qualitative data from a trial population in Uganda

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 22, Issue SUPPL. 1, 2010, Pages 35-43

  Foster, S D ^a   Nakamanya, S ^b   Kyomuhangi, R ^b   Amurwon, J ^b   Namara, G ^b   Amuron, B ^b   Nabiryo, C ^c   Birungi, J ^c   Wolff, B ^b   Jaffar, S ^d   Grosskurth, H ^b  

^a BOSTON UNIVERSITY   (United States)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c THE AIDS SUPPORT ORGANIZATION   (Uganda)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

adherence; ART delivery; disclosure; medicine companion; stigma

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGED; ARTICLE; CAREGIVER; CHILD; DATA ANALYSIS; DIVORCE; FEMALE; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RELIABILITY; SEX RATIO; UGANDA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-RETROVIRAL AGENTS; CHILD; DEVELOPING COUNTRIES; FEMALE; FRIENDS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PLAN IMPLEMENTATION; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SOCIOECONOMIC FACTORS; SPOUSES; UGANDA; YOUNG ADULT;

EID: 77955236255     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120903500027     Document Type: Article

References (30)

1. Amuron, B., Coutinho, A., Grosskurth, H., Nabiryo, C., Birungi, J., Namara, G., et al. (2007). A cluster- randomised trial to compare home-based with healthfacility-based antiretroviral treatment in Uganda: Study design and baseline findings. Open AIDS Journal, 1, 21-27.
2. Behforouz, H.L., Farmer, P.E., & Mukherjee, J.S. (2004). From directly observed therapy to accompagnateurs: Enhancing AIDS treatment outcomes in Haiti and in Boston. Clinical Infectious Diseases, 38(s5), S429-S436.
3. Braitstein, P., Brinkhof, M.W., Dabis, F., Schechter, M., Boulle, A., Miotti, P., et al. (2006). Mortality of HIV- infected patients in the first year of antiretroviral therapy: Comparison between low-income and high- income countries. Lancet, 367(9513), 817-824.
4. Byakika-Tusiime, J., Oyugi, J.H., Tumwikirize, W.A., Katabira, E.T., Mugyenyi, P.N., & Bangsberg, D.R. (2005). Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy. International Journal of STD & AIDS, 16(1), 38-41.
5. Coetzee, D., Hildebrand, K., Boulle, A., Maartens, G., Louis, F., Labatala, V., et al. (2004). Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS, 18(6), 887-895.
6. Cox, H.S., Morrow, M., & Deutschmann, P.W. (2008). Long term efficacy of DOTS regimens for tuberculosis: Systematic review. British Medical Journal, 336, 457458.
7. Davies, G.R., & Squire, S.B. (2008). Doubts about DOTS. BMJ, 336(7642), 457-458.
8. Etard, J.F., Ndiaye, I., Thierry-Mieg, M., Gueye, N.F., Gueye, P.M., Laniece, I., et al. (2006). Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: A 7-year cohort study. AIDS, 20(8), 1181-1189.
9. Farmer, P., Leandre, F., Mukherjee, J., Gupta, R., Tarter, L., & Kim, J.Y. (2001). Community-based treatment of advanced HIV disease: Introducing DOT-HAART (directly observed therapy with highly active antire- troviral therapy). Bulletin of the World Health Organization, 79(12), 1145-1151.
10. Ferradini, L., Jeannin, A., Pinoges, L., Izopet, J., Odhiambo, D., Mankhambo, L., et al. (2006). Scaling up of highly active antiretroviral therapy in a rural district of Malawi: An effectiveness assessment. Lancet, 367(9519), 1335-1342.
11. Fielding, K.L., Charalambous, S., Stenson, A.L., Pemba, L.F., Martin, D.J., Wood, R., et al. (2008). Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: A cohort study. BMC Infectious Diseases, 8, 93-100.
12. Friedland, G., Abdool Karim, S., Abdool Karim, Q., Lalloo, U., Jack, C., Gandhi, N., et al. (2004). Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries. Clinical Infectious Diseases, 38(Suppl. 5), S421-S428.
13. Hardon, A.P., Akurut, D., Comoro, C., Ekezie, C., Irunde, H.F., Gerrits, T., et al. (2007). Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in Africa. AIDS Care, 19(5), 658-665.
14. Jaffar, S., Amuron, B., Foster, S.D., Birungi, J., Levin, J., Namara, G., et al. (2009). Rates of virological failure in patients treated in a home-based versus a facility- based HIV-care model in Jinja, southeast Uganda: A cluster-randomised equivalence trial. The Lancet, 374(9707), 2080-2089.
15. Karamagi, C.A.S., Tumwine, J.K., Tylleskar, T., & Heggenhougen, K. (2006). Intimate partner violence against women in eastern Uganda: Implications for HIV prevention. BMC Public Health, 6(1), 284.
16. Koenig, M.A., Lutalo, T., Zhao, F., Nalugoda, F., Wabwire-Mangen, F., Kiwanuka, N., et al. (2003). Domestic violence in rural Uganda: Evidence from a community-based study. Bulletin of the World Health Organization, 81, 53-60.
17. Laurent, C., Diakhate, N., Gueye, N.F., Toure, M.A., Sow, P.S., Faye, M.A., et al. (2002). The Senegalese government's highly active antiretroviral therapy initiative: An 18-month follow-up study. AIDS, 16(10), 1363-1370.
18. Liechty, C., & Bangsberg, D. (2003). Doubts about DOT: Antiretroviral therapy for resource-poor countries. AIDS, 17(9), 1383-1387.
19. Marazzi, M.C., Liotta, G., Germano, P., Guidotti, G., Altan, A.D., Ceffa, S., et al. (2008). Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings. AIDS Research and Human Retroviruses, 24(4), 555-560.
20. Medecins sans frontiere (MSF), Department of Public Health of the University of Cape Town, & The Provincial Administration of the Western Cape. (2003). Antiretroviral therapy in primary health care: Experience of the Khayelitsha Programme in South Africa. Geneva: WHO.
21. Mermin, J., Were, W., Ekwaru, J.P., Moore, D., Downing, R., Behumbiize, P., et al. (2008). Mortality in HIV- infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: A prospective cohort study. Lancet, 371(9614), 752-759.
22. Mills, E., Nachega, J., Bangsberg, D., Singh, S., Rachlis, B., Wu, P., et al. (2006). Adherence to HAART: A systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Medicine, 3(11), e438.
23. Nachega, J.B., Knowlton, A.R., Deluca, A., Schoeman, J.H., Watkinson, L., Efron, A., et al. (2006). Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. Journal of Acquired Immune Deficiency Syndromes, 43(1), S127-S133.
24. Ssebbanja, P.K. (2007). United against AIDS: The story of TASO. Oxford and Kampala: Strategies for Hope Trust and The AIDS Support Organization (TASO).
25. Stringer, J.S., Zulu, I., Levy, J., Stringer, E.M., Mwango, A., Chi, B.H., et al. (2006). Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: Feasibility and early outcomes. JAMA, 296(7), 782-793.
26. Toure, S., Kouadio, B., Seyler, C., Traore, M., Dakoury- Dogbo, N., Duvignac, J., et al. (2008). Rapid scaling- up of antiretroviral therapy in 10,000 adults in Cote d'Ivoire: 2-year outcomes and determinants. AIDS, 22(7), 873-882.
27. Vicente, M., Hodgson, J., Massidda, O., Tonjum, T., Henriques-Normark, B., & Ron, E.Z. (2006). The fallacies of hope: Will we discover new antibiotics to combat pathogenic bacteria in time? FEMS Microbiology Reviews, 30(6), 841-852.
28. Wanyama, J., Castelnuovo, B., Wandera, B., Mwebaze, P., Kambugu, A., Bangsberg, D.R., et al. (2007). Belief in divine healing can be a barrier to antiretroviral therapy adherence in Uganda. AIDS, 21(11), 1486-1487.
29. Ware, N.C., Idoko, J., Kaaya, S., Biraro, I.A., Wyatt, M.A., Agbaji, O., et al. (2009). Explaining adherence success in Sub-Saharan Africa: An ethnographic study. PLoS Medicine, 6, e1000011.
30. Whetten-Goldstein, K., Nguyen, T.Q., & Sugarman, J. (2001). So much for keeping secrets: The importance of considering patients' perspectives on maintaining confidentiality. AIDS Care, 13(4), 457-466.